|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Generics: Streamline and Stimulate
Author(s)Kevin Gopal
Brussels-Lack of intellectual property protection is not causing the erosion of European pharma, reports the European Generics Association.
Advertisement
Articles in this issue
about 25 years ago
Decision Making at Digital Speedabout 25 years ago
Mergers: Big Pharma Shrinks Someabout 25 years ago
Grace Under Fireabout 25 years ago
Get Ready to Merge or Divergeabout 25 years ago
Pharma's Quantum Shuffleabout 25 years ago
Science-Driven MarketingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5